Virtual cells will still be just computer models. Synthetic biology’s masterpiece—in the word’s original sense of a work ...

A new review maps how anesthetics and surgical stress disrupt circadian and melatonin signaling, and why better-designed ...

Cumulus Neuroscience, the digital biomarker company behind the NeuLogiq® Platform, and Transpharmation Ltd., a scientist-led ...

However, just like coding agents, many of those SRE agents rely on costly frontier models. This week Datadog introduced a ...

A validated translational platform linking lesion drug penetration to Phase 3 trial outcomes offers a new way to design ...

Transdermal drug delivery systems are pharmaceutical formulation systems that combine active ingredients with carriers such ...

Group chairman and CEO of precision instruments manufacturer HORIBA, Atsushi Horiba has been named an honorary fellow of ...

Siemens Digital Industries Software unveiled "Intelligence Center X," an integrated enterprise AI agent platform, on the 13th ...

The global threat of antimicrobial resistance necessitates an integrated roadmap to accelerate development and equitable use ...

How an oncologist’s sci-fi insight, layoffs at a pharma giant, and the culture of Research Triangle Park birthed a major cancer innovation.

SR One's Simeon George argues that the biggest returns from AI in drug development come from improving early-stage decisions, not from predicting ...

GSK (LSE:GSK) announced a new collaboration with Chai Discovery to apply AI-driven protein design in its drug discovery ...